Zymeworks Inc
NYSE:ZYME
Zymeworks Inc
Other Current Assets
Zymeworks Inc
Other Current Assets Peer Comparison
Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors
Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Zymeworks Inc
NYSE:ZYME
|
Other Current Assets
$19.1m
|
CAGR 3-Years
13%
|
CAGR 5-Years
38%
|
CAGR 10-Years
N/A
|
|
Theratechnologies Inc
TSX:TH
|
Other Current Assets
$2.7m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
18%
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Other Current Assets
$4.7m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
74%
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Other Current Assets
$4.3m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Other Current Assets
$10.2m
|
CAGR 3-Years
14%
|
CAGR 5-Years
9%
|
CAGR 10-Years
59%
|
|
Spectral Medical Inc
TSX:EDT
|
Other Current Assets
CA$980k
|
CAGR 3-Years
14%
|
CAGR 5-Years
15%
|
CAGR 10-Years
11%
|
See Also
What is Zymeworks Inc's Other Current Assets?
Other Current Assets
19.1m
USD
Based on the financial report for Dec 31, 2023, Zymeworks Inc's Other Current Assets amounts to 19.1m USD.
What is Zymeworks Inc's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
38%
Over the last year, the Other Current Assets growth was 0%. The average annual Other Current Assets growth rates for Zymeworks Inc have been 13% over the past three years , 38% over the past five years .